Insiders · TAOX

Robert Weinstein

Chief Financial Officer at TAO Synergies Inc. (TAOX) since June 2021

Robert Weinstein has filed 29 insider reports with the SEC since June 2021, as chief Financial Officer at TAO Synergies Inc. (TAOX), director at XWELL, Inc. (XWEL) and director at PharmaCyte Biotech, Inc. (PMCB) and at 2 more companies. Robert Weinstein made no open-market purchases or sales in the last 12 months. The latest filing, on November 18, 2026, reports grant or award at TAO Synergies Inc. (TAOX).

Filings
29
Companies
5
Bought on market
$12.4K
Sold on market
$240K

Companies where Robert Weinstein is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
TAO Synergies Inc. logo
TAOX
TAO Synergies Inc.
Chief Financial Officersince June 202116,574$31.6K$1.73Nov 18, 2026
XWELL, Inc. logo
XWEL
XWELL, Inc.
Director265,231$12.4K$208K$0.25$0.4655+86%Sep 3, 2026
PharmaCyte Biotech, Inc. logo
PMCB
PharmaCyte Biotech, Inc.
Directorsince November 202241,250$5.37Jul 17, 2026
Petros Pharmaceuticals, Inc. logo
PTPI
Petros Pharmaceuticals, Inc.
Chief Accounting Officersince June 2026636,004Jun 25, 2026
Oblong, Inc. logo
TWAV
Oblong, Inc.
Directorsince May 2023$1.16Jun 1, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Robert Weinstein.

Compare Robert Weinstein with

Other insiders at the same companies

Questions about Robert Weinstein

What is Robert Weinstein's role at TAO Synergies Inc.?
Robert Weinstein reports to the SEC as chief Financial Officer at TAO Synergies Inc. (TAOX), according to the latest filing on November 18, 2026. Robert Weinstein has also filed as director at XWELL, Inc. (XWEL), director at PharmaCyte Biotech, Inc. (PMCB), chief Accounting Officer at Petros Pharmaceuticals, Inc. (PTPI) and director at Oblong, Inc. (TWAV).
How many shares does Robert Weinstein own?
After the latest filing that states it, Robert Weinstein directly owned 16,574 shares of TAO Synergies Inc. (TAOX), 265,231 shares of XWELL, Inc. (XWEL), 41,250 shares of PharmaCyte Biotech, Inc. (PMCB) and 636,004 shares of Petros Pharmaceuticals, Inc. (PTPI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert Weinstein bought or sold stock recently?
The most recent open-market purchase was on May 30, 2023: bought 25,000 shares of XWELL, Inc. (XWEL) for $6,175 at an average of $0.25. The most recent open-market sale was on December 16, 2022: sold 27,000 shares of Synaptogenix, Inc. (TAOX) for $31.6K at an average of $1.17.
How do I get alerts when Robert Weinstein files?
Follow Robert Weinstein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert Weinstein filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Robert Weinstein (SEC CIK 0001213709). Totals count each trade once, skipping amendments whose original is on file, from Jun 15, 2021 on. View on SEC EDGAR